Cargando…
Can Mediastinal Lymphadenopathy Signal Pericarditis, Pericardial Effusion, and Severe Disease in a COVID-19 Patient?
Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has created a global pandemic. As we try to understand the virus, we are learning that it can affect many organ systems. Most commonly coronavirus disease 2019 (COVID-19) virus affects the respiratory tract and the lungs impairing oxygen t...
Autores principales: | Khan, Nabeel, Pandit, Sarbagya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921382/ https://www.ncbi.nlm.nih.gov/pubmed/35308697 http://dx.doi.org/10.7759/cureus.22160 |
Ejemplares similares
-
Acute Pericarditis and Pericardial Effusion in a Hypertensive COVID-19 Patient
por: Naqvi, Syeda Ghadeer Zehra, et al.
Publicado: (2020) -
COVID-19 Presenting as Recurrent Pericardial Effusion
por: Tran, Dena H, et al.
Publicado: (2021) -
An Unusual Case of Chronic Kidney Disease with Mediastinal Lymphadenopathy
por: Thandra, Abhishek, et al.
Publicado: (2018) -
Multimodality Imaging for Pericardial Epithelioid Angiosarcoma Presenting With Pericardial Effusion and Constrictive Pericarditis
por: Kim, Se-Eun, et al.
Publicado: (2022) -
Minoxidil-Induced Pleuro-Pericardial Effusion With Tamponade
por: Akinleye, Akintayo, et al.
Publicado: (2023)